Amid the near-total Israeli blockade, those in Gaza are facing a new threat to their lives — paralytic diseases. According to Nasser Hospital’s head of pediatrics, Dr. Ahmed Al-Farra, “Before the war, ...
Roche presented new data at ECTRIMS 2025 confirming that OCREVUS provides sustained protection against disability progression and maintains a con ...
Ocrevus subcutaneous maintains consistent benefit-risk profile after two years -- New late-breaking data confirms Ocrevus ...
Basel, 24 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presents new data for OCREVUS® (ocrelizumab) and the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib at the 41st ...
In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
Riad Sherif, M.D., Chief Executive Officer of Oculis, commented : “It is a privilege to collaborate with Pitié-Salpêtrière Hospital, a world-renowned center for modern neurology, on the Phase 2 ACUITY ...
While vitamins can aid in managing symptoms, it's best to consult a doctor for a comprehensive treatment plan.
An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...
In the brain, it is not only important that nerve cells send signals, but also how quickly they can do so. In order for ...
The growth factor erythropoietin (EPO), known from hematopoiesis, also has important effects in the brain – particularly on so-called oligodendrocytes. These cells are responsible for the formation of ...
A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) ...
New research uncovers how cancer-induced nerve injury drives resistance to anti-PD-1 therapy, revealing potential strategies to enhance treatment efficacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback